The authors' work is supported by the European Network for Translational Research in Atrial Fibrillation (EUTRAF, No. 261057), the German Federal Ministry of Education and Research (AF Competence ...

Dr. Naccarelli answers the question: 'What Is Sotalol, How Does It Work?' — -- Question: I have been placed on an antiarrhythmic drug called sotalol for my heart rhythm problem. How does it work ...

Abstract and Introduction Evidence for a Proarrhythmic Effect of LV Pacing Evidence For an Antiarrhythmic Effect of CRT Conclusions References There are very few experimental studies that examined ...

This is a preview. Log in through your library . Abstract Purpose Long-term usage of the antiarrhythmic drug digoxin has been connected to lowered risk of prostate cancer. A recent study has suggested ...

CHICAGO -- The angina drug ranolazine (Ranexa) did not help prevent ventricular arrhythmia events in high-risk implantable cardioverter-defibrillator (ICD) device patients in a randomized trial, but ...

CHICAGO — Continuing previously ineffective antiarrhythmic drug therapy after pulmonary vein isolation was associated with lower prevalence of atrial tachyarrhythmias at 1 year, according to results ...

Doctors often prescribe antiarrhythmic drugs for patients experiencing atrial fibrillation (AF). While these drugs do work to restore regular rhythm to the heartbeat, scientists and doctors are ...

Background: Of the antiarrhythmic agents currently marketed in Canada, 5 are commonly used to treat atrial fibrillation (AF). The impact of contraindications, warnings and precautions for the use of ...

PARIS — Early radiofrequency ablation was superior to antiarrhythmic drugs to delay the progression to persistent atrial fibrillation among patients with drug-refractory paroxysmal AF, according to ...

Findings reported in The American Journal of Pathology suggest dofetilide may counteract pathological changes in potassium channels associated with pulmonary arterial hypertension in humans and rats ...

heart ecg arrhythmia The FDA has approved the Prior Approval Supplement for Bretylium Tosylate Injection, allowing ANI Pharmaceuticals to market the once discontinued antiarrhythmic agent. The Food ...